New blood test spots silent liver metastases in pancreatic cancer patients
NCT ID NCT07224802
First seen Nov 05, 2025 · Last updated May 23, 2026 · Updated 26 times
Summary
This study tested a new blood test that looks for tiny particles (exosomes) released by cancer cells to find early signs of liver spread in people with pancreatic cancer. The goal was to identify patients at high risk before surgery, so doctors can choose the best treatment plan. The study involved 372 participants and used machine learning to analyze the results.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PDAC - PANCREATIC DUCTAL ADENOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
City of Hope Medical Center
Duarte, California, 91016, United States
Conditions
Explore the condition pages connected to this study.